QLUPOD AG: QluPod on course for international success: participation in renowned health technology trade fairs in Dubai and Rome

Herisau (pta025/05.10.2023/14:00 UTC+2)

Press Release QluPod AG

Herisau, Switzerland QluPod AG, 05 October 2023 (www.qlupod.com)

As a start-up in the fields of health technology and telemedicine, QluPod AG is pleased to announce its participation in two important trade fairs for the health tech sector in Dubai and Rome. In Dubai, the company was even selected to participate in a high-profile panel discussion on "Healthcare Innovations for a sustainable Future".

Participation in the "Future Innovation Summit" in Dubai

The Dubai show, which will take place at the Jumeirah Beach Hotel from 10-11 October 2023, will gather leaders from the technology industry during the two-day summit to showcase the latest innovations, trends and developments. The aim is to create an inspiring community whose goal is to shape the future of education, sustainability, fintech, healthcare and many other topics.

Aidan Burley, Head of Sales & Marketing, who will participate in the panel discussion on behalf of QluPod AG said: "We are proud to be a participant in this important trade fair and to present our innovative telemedicine solutions to an international audience. This event provides an excellent opportunity to demonstrate and actively shape our commitment to healthcare innovation" adding "it is great to be participating in this prestigious summit for future healthcare innovations."

Hope for award at gala

The highlight of the fair in Dubai is a gala at which the most innovative companies will be honoured with an award. Aidan Burley expressed his confidence: "Our pioneering products such as the QluPod Health Monitor and our QluPod Telemedicine App have the potential to win one of the coveted awards. We hope that our efforts in telemedicine and our innovative health technology solutions and services will be recognised."

Shaping the future: QluPod AG presents itself at "Frontiers Health" in Rome

QluPod AG's international orientation is also reflected in its participation in "Frontiers Health" from 8 to 10 November 2023 in Rome. The focus of the trade fair is on the digital transformation of global healthcare, digital therapeutics as well as breakthrough technologies and investments for the development of ecosystems. This prestigious event not only brings companies together, but also creates a platform for industry-leading thought leaders, policy makers and innovative companies.

QluPod AG: Pioneering digital health solutions

At the Rome show, the company will introduce the QluPod health monitor for measuring six vital signs with just one device and direct communication with the user's health care providers via the QluPod telemedicine app for iOS and Android. "We are proud to be participants in this outstanding event," said Stephen Dando, Founder and Chairman of the Board of QluPod. "Participating in Frontiers Health is a great opportunity for our company to showcase our pioneering telemedicine solutions and services to an international audience. The fair allows us to exchange ideas with other experts from the healthcare industry. We have the opportunity to learn from best practices and explore potential partnerships to shape the future of healthcare together."

Global expansion and partnerships

QluPod AG sees the "Frontiers Health" trade fair in Rome as a valuable opportunity to increase its global reach, establish new contacts and partnerships, and expand and consolidate its position as a pioneer in the fields of digital health solutions and telemedicine. Interested parties and visitors are cordially invited to visit the company at the trade fair and learn about the latest developments in health technology.

About QluPod:

QluPod AG is a start-up company in the field of telemedicine and develops innovative solutions to make patient care efficient and cost-effective. With the QluPod device and associated software, the company aims to shape the future of healthcare. The offer is aimed at hospitals, care facilities, medical professionals as well as private individuals who want to monitor their health on their own responsibility.

For more information about QluPod AG and our products, visit our website at www.qlupod.com.

Disclaimer:

This publication constitutes neither an offer to sell nor a solicitation to buy any securities. To the extent that forward-looking statements are contained in this document, they are not statements of fact and are identified by the words "expect", "believe", "estimate", "intend", "seek", "assume" and similar expressions. These statements express the intentions, beliefs or current expectations and assumptions of QluPod AG and are based on current plans, estimates and projections made by QluPod AG to the best of its knowledge, but are not guarantees of future performance. Forward-looking statements are subject to risks and uncertainties, most of which are difficult to predict and are usually beyond the control of QluPod AG. It should be taken into account that actual events or developments may differ materially from those indicated or contained in the forward-looking statements.

(end)

Emitter:	QLUPOD AG Industriestrasse 28 9100 Herisau Switzerland
Contact Person:	Steve Dando
Phone:	+41 71 510 05 45
E-Mail:	ir@qlupod.com
Website:	qlupod.com
ISIN(s):	CH1222316429 (Share)
Stock Exchange(s):	-
Other Stock Exchanges:	Regelmaessige Kursfeststellung Schweiz